CATEGORY
EMA
- ABPI
- ACE
- ACIS
- Adelaide
- Aetsa
- Agenas
- AHRQ
- AIFA
- AMNOG
- ANVISA
- AOTMiT
- AQuAS
- Behandlingsraadet
- BfArM
- Biocat
- C2H
- CADTH
- CDC
- CDE
- CMS
- COFEPRIS
- CONITEC
- Digemid
- EFPIA
- EMA
- EPF
- Eucope
- EUnetHTA
- EuropaBio
- European Commission
- Euskadi
- FDA
- FOPH
- G-BA
- Gesundheit Österreich
- HAS
- Health Technology Wales
- Healthcare Improvement Scotland
- HHS
- HIQA
- HTAi
- ICER
- IECS
- IETS
- IHE
- IHEA
- INAHTA
- IQWiG
- ISPOR
- KCE
- Medicaid
- Medicines for Europe
- MHRA
- MSP
- NECA
- NHS
- nHTA
- NICE
- NIH
- NIHO
- NIHR
- NIPH
- NSW Health
- NZa
- OHE
- OYS
- PBS
- pCPA
- Pharmac
- PhRMA
- Salute
- SBU
- Schönermark Kielhorn Collegen
- SGK
- TÄ°TCK
- TLV
- WHO
- ZonMw
- Zorginstituut Nederland
European Agency Launches New Platform to Monitor Drug Shortages
European Medicines Agency Champions Real-World Data for Safer Medical Practices
Bristol Myers Squibb Gains CHMP Nod for Opdivo-Yervoy Combo in Metastatic Colorectal Cancer
Bristol Myers Squibb Advances Dual Immunotherapy for Colorectal Cancer
CVMP Drives Veterinary Advancements with New Approvals and Guidelines
Dupixent Gains EU Approval for Young EoE Patients
EU CHMP Recommends AstraZeneca’s Wainzua for Rare Neuropathy Treatment
Regulators Push for Coordinated Mpox Vaccine Trials
Pliant Therapeutics’ Bexotegrast Shows Promise in Treating Liver Disease
EMA Recommends Approval of Ten New Medicines, Enhancing Healthcare Options Across Europe
European Parliament’s Bold Stance Strengthens EU Health Investments
EMA Confirms Non-Renewal of Translarna for Duchenne Muscular Dystrophy
Novartis’ Kisqali Poised to Expand Treatment Options for Early Breast Cancer in Europe
Alhemo® Receives Positive Recommendation for Haemophilia Treatment in Europe
EMA and HMA Launch Strategy to Boost EU Medicines System by 2028